Page 26 - 《中国药房》2023年24期

rebral venous sinus thrombosis：a randomized controlled EAPCI expert consensus statement on catheter-based left
trial[J]. Eur J Neurol，2012，19（7）：1030-1036. atrial appendage occlusion： an update[J]. Europace，2020，
[35] COUTINHO J，DE BRUIJN S F，DEVEBER G，et al. An‐ 22（2）：184.
ticoagulation for cerebral venous sinus thrombosis[J]. Co‐ [45] TAY E，PAUL B，SHARP J，et al. Left atrial appendage oc‐
chrane Database Syst Rev，2011，2011（8）：CD002005. clusion for ischemic stroke prevention in patients with
[36] FERRO J M，COUTINHO J M，DENTALI F，et al. Safety non-valvular atrial fibrillation：clinical expert opinion and
and efficacy of dabigatran etexilate vs dose-adjusted war‐ consensus statement for the Asian-Pacific region[J]. J In‐
farin in patients with cerebral venous thrombosis：a ran‐ terv Card Electrophysiol，2021，61（2）：269-281.
domized clinical trial[J]. JAMA Neurol，2019，76（12）： [46] SAW J，HOLMES D R，CAVALCANTE J L，et al. SCAI/
1457-1465. HRS expert consensus statement on transcatheter left
[37] YAGHI S，SHU L Q，BAKRADZE E，et al. Direct oral an‐ atrial appendage closure[J]. JACC Cardiovasc Interv，
ticoagulants versus warfarin in the treatment of cerebral 2023，16（11）：1384-1400.
venous thrombosis（ACTION-CVT）：a multicenter inter‐ [47] EITEL C，KOCH J，SOMMER P，et al. Novel oral anti-
national study[J]. Stroke，2022，53（3）：728-738. coagulants in a real-world cohort of patients undergoing
[38] PAN L Q，WANG M Q，ZHOU D，et al. Efficacy and catheter ablation of atrial fibrillation[J]. Europace，2013，
safety of rivaroxaban in cerebral venous thrombosis：in‐ 15（11）：1587-1593.
sights from a prospective cohort study[J]. J Thromb [48] WU S，YANG Y M，ZHU J，et al. Meta-analysis of ef-
Thrombolysis，2022，53（3）：594-600. ficacy and safety of new oral anticoagulants compared
[39] BOSE G，GRAVELINE J，YOGENDRAKUMAR V，et al. with uninterrupted vitamin K antagonists in patients under‐
Direct oral anticoagulants in treatment of cerebral venous going catheter ablation for atrial fibrillation[J]. Am J Car‐
thrombosis：a systematic review[J]. BMJ Open，2021，11 diol，2016，117（6）：926-934.
（2）：e040212. [49] KARASOY D，GISLASON G H，HANSEN J，et al. Oral
[40] LI H J，YAO M L，LIAO S J，et al. Comparison of novel anticoagulation therapy after radiofrequency ablation of
oral anticoagulants and vitamin K antagonists in patients atrial fibrillation and the risk of thromboembolism and se‐
with cerebral venous sinus thrombosis on efficacy and rious bleeding：long-term follow-up in nationwide cohort
safety：a systematic review[J]. Front Neurol，2020，11： of Denmark[J]. Eur Heart J，2015，36（5）：307-14a.
597623. [50] FLEDDERMANN A，ECKERT R，MUSKALA P，et al.
[41] 顾建平，徐克，滕皋军. 下肢深静脉血栓形成介入治疗规 Efficacy of direct acting oral anticoagulant drugs in treat‐
范的专家共识：第 2 版[J]. 介入放射学杂志，2019，28 ment of left atrial appendage thrombus in patients with
（1）：1-10. atrial fibrillation[J]. Am J Cardiol，2019，123（1）：57-62.
GU J P，XU K，TENG G J. Expert consensus on the stan‐ [51] ROBINSON A A，TRANKLE C R，EUBANKS G，et al.
dard of interventional therapy for lower extremity deep ve‐ Off-label use of direct oral anticoagulants compared with
nous thrombosis：2nd edition[J]. J Interv Radiol，2019，28 warfarin for left ventricular thrombi[J]. JAMA Cardiol，
（1）：1-10. 2020，5（6）：685-692.
[42] KAKKOS S K，GOHEL M，BAEKGAARD N，et al. Edi‐ [52] JONES D A，WRIGHT P，ALIZADEH M A，et al. The
tor’s choice： European Society for Vascular Surgery use of novel oral anticoagulants compared to vitamin K
（ESVS）2021 clinical practice guidelines on the manage‐ antagonists（warfarin）in patients with left ventricular
ment of venous thrombosis[J]. Eur J Vasc Endovasc Surg， thrombus after acute myocardial infarction[J]. Eur Heart J
2021，61（1）：9-82. Cardiovasc Pharmacother，2021，7（5）：398-404.
[43] 中华医学会心血管病学分会，中华心血管病杂志编辑委 [53] OTTO C M，NISHIMURA R A，BONOW R O，et al. 2020
员会 . 中国左心耳封堵预防心房颤动卒中专家共识： ACC/AHA guideline for the management of patients with
2019[J] . 中华心血管病杂志，2019，47（12）：937-955. valvular heart disease：a report of the American College of
Chinese Society of Cardiology，Editorial Board of Cardiology/American Heart Association Joint Committee
Chinese Journal of Cardiology. 2019 Chinese Society of on clinical practice guidelines[J]. Circulation，2021，143
Cardiology（CSC） expert consensus statement on left （5）：e72-e227.
atrial appendage closure in the prevention of stroke in pa‐ [54] HINDRICKS G，POTPARA T，DAGRES N，et al. 2020
tients with atrial fibrillation[J]. Chin J Cardiol，2019，47 ESC guidelines for the diagnosis and management of
（12）：937-955. atrial fibrillation developed in collaboration with the
[44] GLIKSON M，WOLFF R，HINDRICKS G，et al. EHRA/ European Association for Cardio-Thoracic Surgery

· 2964 · China Pharmacy 2023 Vol. 34 No. 24 中国药房 2023年第34卷第24期